糖尿病患者胰腺的影像学评估
本文综述了CT、MR、US及影像组学在评估糖尿病患者胰腺改变中的应用。既往尸体活检已知糖尿病患者胰腺体积减小,近二十年影像学研究试图确定胰腺其他变化。影像学检查有望提供可靠的糖尿病相关信息,影像组学可识别难以检测的特征并辅助诊断和预测糖尿病。
要点
- 糖尿病患者胰腺体积减小早已由尸体活检证实,影像学可无创评估胰腺体积变化。
- CT、MR和US等多种影像方法可用于探索糖尿病患者的胰腺改变。
- 影像组学可提供有价值信息,识别难以检测的特征,辅助诊断和预测糖尿病。
核心结论
- 影像学研究有望产生关于糖尿病的可靠信息,影像组学可提供越来越有价值的信息以识别一些不可检测的特征,并通过胰腺影像帮助诊断和预测糖尿病的发生。
研究设计与样本
- 综述,总结关于使用不同影像方法(如CT、MR和US)及影像组学探索糖尿病患者胰腺改变的当前知识。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Diabetes mellitus (DM) is becoming a global epidemic and its diagnosis and monitoring are based on laboratory testing which sometimes have limitations. The pancreas plays a key role in metabolism and is involved in the pathogenesis of DM. It has long been known through cadaver biopsies that pancreas volume is decreased in patients with DM. With the development of different imaging modalities over the last two decades, many studies have attempted to determine whether there other changes occurred in the pancreas of diabetic patients. This review summarizes current knowledge about the use of different imaging approaches (such as CT, MR, and US) and radiomics for exploring pancreatic changes in diabetic patients. Imaging studies are expected to produce reliable information regarding DM, and radiomics could provide increasingly valuable information to identify some undetectable features and help diagnose and predict the occurrence of diabetes through pancreas imaging.
引用
- Zeng, Wang, Cheng, et al. Imaging evaluation of the pancreas in diabetic patients. Abdom Radiol (NY). 2021. PMID: 34786594. doi:10.1007/s00261-021-03340-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。